Table of Content

1 Ofatumumab Market Overview
1.1 Ofatumumab Product Overview
1.2 Ofatumumab Market Segment by Type
1.2.1 Patent
1.2.2 Generic
1.3 Global Ofatumumab Market Size by Type
1.3.1 Global Ofatumumab Market Size Overview by Type (2024-2034)
1.3.2 Global Ofatumumab Historic Market Size Review by Type (2024-2024)
1.3.3 Global Ofatumumab Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Ofatumumab Sales Breakdown by Type (2024-2024)
1.4.2 Europe Ofatumumab Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Ofatumumab Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Ofatumumab Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Ofatumumab Sales Breakdown by Type (2024-2024)
2 Global Ofatumumab Market Competition by Company
2.1 Global Top Players by Ofatumumab Sales (2024-2024)
2.2 Global Top Players by Ofatumumab Revenue (2024-2024)
2.3 Global Top Players by Ofatumumab Price (2024-2024)
2.4 Global Top Manufacturers Ofatumumab Manufacturing Base Distribution, Sales Area, Product Type
2.5 Ofatumumab Market Competitive Situation and Trends
2.5.1 Ofatumumab Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Ofatumumab Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ofatumumab as of 2022)
2.7 Date of Key Manufacturers Enter into Ofatumumab Market
2.8 Key Manufacturers Ofatumumab Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Ofatumumab Status and Outlook by Region
3.1 Global Ofatumumab Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Ofatumumab Historic Market Size by Region
3.2.1 Global Ofatumumab Sales in Volume by Region (2024-2024)
3.2.2 Global Ofatumumab Sales in Value by Region (2024-2024)
3.2.3 Global Ofatumumab Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Ofatumumab Forecasted Market Size by Region
3.3.1 Global Ofatumumab Sales in Volume by Region (2024-2034)
3.3.2 Global Ofatumumab Sales in Value by Region (2024-2034)
3.3.3 Global Ofatumumab Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Ofatumumab by Application
4.1 Ofatumumab Market Segment by Application
4.1.1 Chemical
4.1.2 Pharmaceutical
4.2 Global Ofatumumab Market Size by Application
4.2.1 Global Ofatumumab Market Size Overview by Application (2024-2034)
4.2.2 Global Ofatumumab Historic Market Size Review by Application (2024-2024)
4.2.3 Global Ofatumumab Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Ofatumumab Sales Breakdown by Application (2024-2024)
4.3.2 Europe Ofatumumab Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Ofatumumab Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Ofatumumab Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Ofatumumab Sales Breakdown by Application (2024-2024)
5 North America Ofatumumab by Country
5.1 North America Ofatumumab Historic Market Size by Country
5.1.1 North America Ofatumumab Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Ofatumumab Sales in Volume by Country (2024-2024)
5.1.3 North America Ofatumumab Sales in Value by Country (2024-2024)
5.2 North America Ofatumumab Forecasted Market Size by Country
5.2.1 North America Ofatumumab Sales in Volume by Country (2024-2034)
5.2.2 North America Ofatumumab Sales in Value by Country (2024-2034)
6 Europe Ofatumumab by Country
6.1 Europe Ofatumumab Historic Market Size by Country
6.1.1 Europe Ofatumumab Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Ofatumumab Sales in Volume by Country (2024-2024)
6.1.3 Europe Ofatumumab Sales in Value by Country (2024-2024)
6.2 Europe Ofatumumab Forecasted Market Size by Country
6.2.1 Europe Ofatumumab Sales in Volume by Country (2024-2034)
6.2.2 Europe Ofatumumab Sales in Value by Country (2024-2034)
7 Asia-Pacific Ofatumumab by Region
7.1 Asia-Pacific Ofatumumab Historic Market Size by Region
7.1.1 Asia-Pacific Ofatumumab Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Ofatumumab Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Ofatumumab Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Ofatumumab Forecasted Market Size by Region
7.2.1 Asia-Pacific Ofatumumab Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Ofatumumab Sales in Value by Region (2024-2034)
8 Latin America Ofatumumab by Country
8.1 Latin America Ofatumumab Historic Market Size by Country
8.1.1 Latin America Ofatumumab Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Ofatumumab Sales in Volume by Country (2024-2024)
8.1.3 Latin America Ofatumumab Sales in Value by Country (2024-2024)
8.2 Latin America Ofatumumab Forecasted Market Size by Country
8.2.1 Latin America Ofatumumab Sales in Volume by Country (2024-2034)
8.2.2 Latin America Ofatumumab Sales in Value by Country (2024-2034)
9 Middle East and Africa Ofatumumab by Country
9.1 Middle East and Africa Ofatumumab Historic Market Size by Country
9.1.1 Middle East and Africa Ofatumumab Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Ofatumumab Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Ofatumumab Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Ofatumumab Forecasted Market Size by Country
9.2.1 Middle East and Africa Ofatumumab Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Ofatumumab Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 BOC Sciences
10.1.1 BOC Sciences Company Information
10.1.2 BOC Sciences Introduction and Business Overview
10.1.3 BOC Sciences Ofatumumab Sales, Revenue and Gross Margin (2024-2024)
10.1.4 BOC Sciences Ofatumumab Products Offered
10.1.5 BOC Sciences Recent Development
10.2 GlaxoSmithKline(GSK)
10.2.1 GlaxoSmithKline(GSK) Company Information
10.2.2 GlaxoSmithKline(GSK) Introduction and Business Overview
10.2.3 GlaxoSmithKline(GSK) Ofatumumab Sales, Revenue and Gross Margin (2024-2024)
10.2.4 GlaxoSmithKline(GSK) Ofatumumab Products Offered
10.2.5 GlaxoSmithKline(GSK) Recent Development
10.3 Lonza Group
10.3.1 Lonza Group Company Information
10.3.2 Lonza Group Introduction and Business Overview
10.3.3 Lonza Group Ofatumumab Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Lonza Group Ofatumumab Products Offered
10.3.5 Lonza Group Recent Development
10.4 Novartis International
10.4.1 Novartis International Company Information
10.4.2 Novartis International Introduction and Business Overview
10.4.3 Novartis International Ofatumumab Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Novartis International Ofatumumab Products Offered
10.4.5 Novartis International Recent Development
10.5 TargetMol Chemicals
10.5.1 TargetMol Chemicals Company Information
10.5.2 TargetMol Chemicals Introduction and Business Overview
10.5.3 TargetMol Chemicals Ofatumumab Sales, Revenue and Gross Margin (2024-2024)
10.5.4 TargetMol Chemicals Ofatumumab Products Offered
10.5.5 TargetMol Chemicals Recent Development
10.6 Hubei Kele Fine Chemical
10.6.1 Hubei Kele Fine Chemical Company Information
10.6.2 Hubei Kele Fine Chemical Introduction and Business Overview
10.6.3 Hubei Kele Fine Chemical Ofatumumab Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Hubei Kele Fine Chemical Ofatumumab Products Offered
10.6.5 Hubei Kele Fine Chemical Recent Development
10.7 Jiangxi Ruiweier Biotechnology
10.7.1 Jiangxi Ruiweier Biotechnology Company Information
10.7.2 Jiangxi Ruiweier Biotechnology Introduction and Business Overview
10.7.3 Jiangxi Ruiweier Biotechnology Ofatumumab Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Jiangxi Ruiweier Biotechnology Ofatumumab Products Offered
10.7.5 Jiangxi Ruiweier Biotechnology Recent Development
10.8 Nantong Feiyu Biological Technology
10.8.1 Nantong Feiyu Biological Technology Company Information
10.8.2 Nantong Feiyu Biological Technology Introduction and Business Overview
10.8.3 Nantong Feiyu Biological Technology Ofatumumab Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Nantong Feiyu Biological Technology Ofatumumab Products Offered
10.8.5 Nantong Feiyu Biological Technology Recent Development
10.9 Shanghai Biochempartner
10.9.1 Shanghai Biochempartner Company Information
10.9.2 Shanghai Biochempartner Introduction and Business Overview
10.9.3 Shanghai Biochempartner Ofatumumab Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Shanghai Biochempartner Ofatumumab Products Offered
10.9.5 Shanghai Biochempartner Recent Development
10.10 Shanghai Macklin Biochemical
10.10.1 Shanghai Macklin Biochemical Company Information
10.10.2 Shanghai Macklin Biochemical Introduction and Business Overview
10.10.3 Shanghai Macklin Biochemical Ofatumumab Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Shanghai Macklin Biochemical Ofatumumab Products Offered
10.10.5 Shanghai Macklin Biochemical Recent Development
10.11 Shanghai Yifei Biotechnology
10.11.1 Shanghai Yifei Biotechnology Company Information
10.11.2 Shanghai Yifei Biotechnology Introduction and Business Overview
10.11.3 Shanghai Yifei Biotechnology Ofatumumab Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Shanghai Yifei Biotechnology Ofatumumab Products Offered
10.11.5 Shanghai Yifei Biotechnology Recent Development
10.12 Tianmen Hengchang Chemical
10.12.1 Tianmen Hengchang Chemical Company Information
10.12.2 Tianmen Hengchang Chemical Introduction and Business Overview
10.12.3 Tianmen Hengchang Chemical Ofatumumab Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Tianmen Hengchang Chemical Ofatumumab Products Offered
10.12.5 Tianmen Hengchang Chemical Recent Development
10.13 Wuhan Topule Biopharmaceutical
10.13.1 Wuhan Topule Biopharmaceutical Company Information
10.13.2 Wuhan Topule Biopharmaceutical Introduction and Business Overview
10.13.3 Wuhan Topule Biopharmaceutical Ofatumumab Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Wuhan Topule Biopharmaceutical Ofatumumab Products Offered
10.13.5 Wuhan Topule Biopharmaceutical Recent Development
10.14 Wuhan Wogeda Biotechnology
10.14.1 Wuhan Wogeda Biotechnology Company Information
10.14.2 Wuhan Wogeda Biotechnology Introduction and Business Overview
10.14.3 Wuhan Wogeda Biotechnology Ofatumumab Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Wuhan Wogeda Biotechnology Ofatumumab Products Offered
10.14.5 Wuhan Wogeda Biotechnology Recent Development
10.15 Wuhan Yingnuo Pharmaceutical Technology
10.15.1 Wuhan Yingnuo Pharmaceutical Technology Company Information
10.15.2 Wuhan Yingnuo Pharmaceutical Technology Introduction and Business Overview
10.15.3 Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Products Offered
10.15.5 Wuhan Yingnuo Pharmaceutical Technology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Ofatumumab Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Ofatumumab Industrial Chain Analysis
11.4 Ofatumumab Market Dynamics
11.4.1 Ofatumumab Industry Trends
11.4.2 Ofatumumab Market Drivers
11.4.3 Ofatumumab Market Challenges
11.4.4 Ofatumumab Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Ofatumumab Distributors
12.3 Ofatumumab Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Patent
Table 2. Major Company of Generic
Table 3. Global Ofatumumab Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Ofatumumab Sales by Type (2024-2024) & (Kg)
Table 5. Global Ofatumumab Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Ofatumumab Sales by Type (2024-2024) & (US& Million)
Table 7. Global Ofatumumab Market Share in Value by Type (2024-2024)
Table 8. Global Ofatumumab Price by Type (2024-2024) & (US$/Kg)
Table 9. Global Ofatumumab Sales by Type (2024-2034) & (Kg)
Table 10. Global Ofatumumab Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Ofatumumab Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Ofatumumab Sales Market Share in Value by Type (2024-2034)
Table 13. Global Ofatumumab Price by Type (2024-2034) & (US$/Kg)
Table 14. North America Ofatumumab Sales by Type (2024-2024) & (Kg)
Table 15. North America Ofatumumab Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Ofatumumab Sales (Kg) by Type (2024-2024)
Table 17. Europe Ofatumumab Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Ofatumumab Sales (Kg) by Type (2024-2024)
Table 19. Asia-Pacific Ofatumumab Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Ofatumumab Sales (Kg) by Type (2024-2024)
Table 21. Latin America Ofatumumab Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Ofatumumab Sales (Kg) by Type (2024-2024)
Table 23. Middle East and Africa Ofatumumab Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Ofatumumab Sales by Company (2024-2024) & (Kg)
Table 25. Global Ofatumumab Sales Share by Company (2024-2024)
Table 26. Global Ofatumumab Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Ofatumumab Revenue Share by Company (2024-2024)
Table 28. Global Market Ofatumumab Price by Company (2024-2024) & (US$/Kg)
Table 29. Global Ofatumumab Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Ofatumumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ofatumumab as of 2022)
Table 32. Date of Key Manufacturers Enter into Ofatumumab Market
Table 33. Key Manufacturers Ofatumumab Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Ofatumumab Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Ofatumumab Sales by Region (2024-2024) & (Kg)
Table 37. Global Ofatumumab Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Ofatumumab Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Ofatumumab Sales Market Share in Value by Region (2024-2024)
Table 40. Global Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2024)
Table 41. Global Ofatumumab Sales by Region (2024-2034) & (Kg)
Table 42. Global Ofatumumab Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Ofatumumab Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Ofatumumab Sales Market Share in Value by Region (2024-2034)
Table 45. Global Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2024-2034)
Table 46. Global Ofatumumab Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Ofatumumab Sales by Application (2024-2024) & (Kg)
Table 48. Global Ofatumumab Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Ofatumumab Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Ofatumumab Sales Market Share in Value by Application (2024-2024)
Table 51. Global Ofatumumab Price by Application (2024-2024) & (US$/Kg)
Table 52. Global Ofatumumab Sales by Application (2024-2034) & (Kg)
Table 53. Global Ofatumumab Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Ofatumumab Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Ofatumumab Sales Market Share in Value by Application (2024-2034)
Table 56. Global Ofatumumab Price by Application (2024-2034) & (US$/Kg)
Table 57. North America Ofatumumab Sales by Application (2024-2024) (Kg)
Table 58. North America Ofatumumab Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Ofatumumab Sales by Application (2024-2024) (Kg)
Table 60. Europe Ofatumumab Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Ofatumumab Sales by Application (2024-2024) (Kg)
Table 62. Asia-Pacific Ofatumumab Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Ofatumumab Sales by Application (2024-2024) (Kg)
Table 64. Latin America Ofatumumab Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Ofatumumab Sales by Application (2024-2024) (Kg)
Table 66. Middle East and Africa Ofatumumab Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Ofatumumab Sales by Country (2024-2024) & (Kg)
Table 68. North America Ofatumumab Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Ofatumumab Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Ofatumumab Sales Market Share in Value by Country (2024-2024)
Table 71. North America Ofatumumab Sales by Country (2024-2034) & (Kg)
Table 72. North America Ofatumumab Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Ofatumumab Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Ofatumumab Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Ofatumumab Sales by Country (2024-2024) & (Kg)
Table 76. Europe Ofatumumab Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Ofatumumab Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Ofatumumab Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Ofatumumab Sales by Country (2024-2034) & (Kg)
Table 80. Europe Ofatumumab Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Ofatumumab Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Ofatumumab Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Ofatumumab Sales by Region (2024-2024) & (Kg)
Table 84. Asia-Pacific Ofatumumab Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Ofatumumab Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Ofatumumab Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Ofatumumab Sales by Region (2024-2034) & (Kg)
Table 88. Asia-Pacific Ofatumumab Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Ofatumumab Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Ofatumumab Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Ofatumumab Sales by Country (2024-2024) & (Kg)
Table 92. Latin America Ofatumumab Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Ofatumumab Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Ofatumumab Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Ofatumumab Sales by Country (2024-2034) & (Kg)
Table 96. Latin America Ofatumumab Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Ofatumumab Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Ofatumumab Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Ofatumumab Sales by Country (2024-2024) & (Kg)
Table 100. Middle East and Africa Ofatumumab Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Ofatumumab Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Ofatumumab Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Ofatumumab Sales by Country (2024-2034) & (Kg)
Table 104. Middle East and Africa Ofatumumab Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Ofatumumab Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Ofatumumab Sales Market Share in Value by Country (2024-2034)
Table 107. BOC Sciences Company Information
Table 108. BOC Sciences Introduction and Business Overview
Table 109. BOC Sciences Ofatumumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 110. BOC Sciences Ofatumumab Product
Table 111. BOC Sciences Recent Development
Table 112. GlaxoSmithKline(GSK) Company Information
Table 113. GlaxoSmithKline(GSK) Introduction and Business Overview
Table 114. GlaxoSmithKline(GSK) Ofatumumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 115. GlaxoSmithKline(GSK) Ofatumumab Product
Table 116. GlaxoSmithKline(GSK) Recent Development
Table 117. Lonza Group Company Information
Table 118. Lonza Group Introduction and Business Overview
Table 119. Lonza Group Ofatumumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 120. Lonza Group Ofatumumab Product
Table 121. Lonza Group Recent Development
Table 122. Novartis International Company Information
Table 123. Novartis International Introduction and Business Overview
Table 124. Novartis International Ofatumumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 125. Novartis International Ofatumumab Product
Table 126. Novartis International Recent Development
Table 127. TargetMol Chemicals Company Information
Table 128. TargetMol Chemicals Introduction and Business Overview
Table 129. TargetMol Chemicals Ofatumumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 130. TargetMol Chemicals Ofatumumab Product
Table 131. TargetMol Chemicals Recent Development
Table 132. Hubei Kele Fine Chemical Company Information
Table 133. Hubei Kele Fine Chemical Introduction and Business Overview
Table 134. Hubei Kele Fine Chemical Ofatumumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 135. Hubei Kele Fine Chemical Ofatumumab Product
Table 136. Hubei Kele Fine Chemical Recent Development
Table 137. Jiangxi Ruiweier Biotechnology Company Information
Table 138. Jiangxi Ruiweier Biotechnology Introduction and Business Overview
Table 139. Jiangxi Ruiweier Biotechnology Ofatumumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 140. Jiangxi Ruiweier Biotechnology Ofatumumab Product
Table 141. Jiangxi Ruiweier Biotechnology Recent Development
Table 142. Nantong Feiyu Biological Technology Company Information
Table 143. Nantong Feiyu Biological Technology Introduction and Business Overview
Table 144. Nantong Feiyu Biological Technology Ofatumumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 145. Nantong Feiyu Biological Technology Ofatumumab Product
Table 146. Nantong Feiyu Biological Technology Recent Development
Table 147. Shanghai Biochempartner Company Information
Table 148. Shanghai Biochempartner Introduction and Business Overview
Table 149. Shanghai Biochempartner Ofatumumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 150. Shanghai Biochempartner Ofatumumab Product
Table 151. Shanghai Biochempartner Recent Development
Table 152. Shanghai Macklin Biochemical Company Information
Table 153. Shanghai Macklin Biochemical Introduction and Business Overview
Table 154. Shanghai Macklin Biochemical Ofatumumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 155. Shanghai Macklin Biochemical Ofatumumab Product
Table 156. Shanghai Macklin Biochemical Recent Development
Table 157. Shanghai Yifei Biotechnology Company Information
Table 158. Shanghai Yifei Biotechnology Introduction and Business Overview
Table 159. Shanghai Yifei Biotechnology Ofatumumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 160. Shanghai Yifei Biotechnology Ofatumumab Product
Table 161. Shanghai Yifei Biotechnology Recent Development
Table 162. Tianmen Hengchang Chemical Company Information
Table 163. Tianmen Hengchang Chemical Introduction and Business Overview
Table 164. Tianmen Hengchang Chemical Ofatumumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 165. Tianmen Hengchang Chemical Ofatumumab Product
Table 166. Tianmen Hengchang Chemical Recent Development
Table 167. Wuhan Topule Biopharmaceutical Company Information
Table 168. Wuhan Topule Biopharmaceutical Introduction and Business Overview
Table 169. Wuhan Topule Biopharmaceutical Ofatumumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 170. Wuhan Topule Biopharmaceutical Ofatumumab Product
Table 171. Wuhan Topule Biopharmaceutical Recent Development
Table 172. Wuhan Wogeda Biotechnology Company Information
Table 173. Wuhan Wogeda Biotechnology Introduction and Business Overview
Table 174. Wuhan Wogeda Biotechnology Ofatumumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 175. Wuhan Wogeda Biotechnology Ofatumumab Product
Table 176. Wuhan Wogeda Biotechnology Recent Development
Table 177. Wuhan Yingnuo Pharmaceutical Technology Company Information
Table 178. Wuhan Yingnuo Pharmaceutical Technology Introduction and Business Overview
Table 179. Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Sales (Kg), Revenue (Million USD), Price (US$/Kg) and Gross Margin (2024-2024)
Table 180. Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Product
Table 181. Wuhan Yingnuo Pharmaceutical Technology Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Ofatumumab Market Trends
Table 185. Ofatumumab Market Drivers
Table 186. Ofatumumab Market Challenges
Table 187. Ofatumumab Market Restraints
Table 188. Ofatumumab Distributors List
Table 189. Ofatumumab Downstream Customers
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Ofatumumab Product Picture
Figure 2. Global Ofatumumab Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Ofatumumab Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Ofatumumab Sales Status and Outlook (2024-2034) & (Kg)
Figure 5. Product Picture of Patent
Figure 6. Global Patent Sales YoY Growth (2024-2034) & (Kg)
Figure 7. Product Picture of Generic
Figure 8. Global Generic Sales YoY Growth (2024-2034) & (Kg)
Figure 9. Global Ofatumumab Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Ofatumumab Sales Market Share by Type in 2022 & 2034
Figure 11. North America Ofatumumab Sales Market Share in Volume by Type in 2022
Figure 12. North America Ofatumumab Sales Market Share in Value by Type in 2022
Figure 13. Europe Ofatumumab Sales Market Share in Volume by Type in 2022
Figure 14. Europe Ofatumumab Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Ofatumumab Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Ofatumumab Sales Market Share in Value by Type in 2022
Figure 17. Latin America Ofatumumab Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Ofatumumab Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Ofatumumab Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Ofatumumab Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Ofatumumab Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Ofatumumab Revenue in 2022
Figure 23. Ofatumumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Chemical
Figure 25. Global Chemical Sales YoY Growth (2024-2034) & (Kg)
Figure 26. Product Picture of Pharmaceutical
Figure 27. Global Pharmaceutical Sales YoY Growth (2024-2034) & (Kg)
Figure 28. Global Ofatumumab Sales by Application (2024-2034) & (US$ Million)
Figure 29. Global Ofatumumab Sales Market Share by Application in 2022 & 2034
Figure 30. North America Ofatumumab Sales Market Share in Volume by Application in 2022
Figure 31. North America Ofatumumab Sales Market Share in Value by Application in 2022
Figure 32. Europe Ofatumumab Sales Market Share in Volume by Application in 2022
Figure 33. Europe Ofatumumab Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Ofatumumab Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Ofatumumab Sales Market Share in Value by Application in 2022
Figure 36. Latin America Ofatumumab Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Ofatumumab Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Ofatumumab Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Ofatumumab Manufacturing Cost Structure
Figure 41. Ofatumumab Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed